LRRK2 p.G2019S PD reported less nocturia and orthostatic hypotension than GBA1 p.N409S PD and noncarriers with PD, and less erectile dysfunction and depression relative to noncarriers with PD. Here, GBA1 is linked to depressive symptom measurement.